#

+91-9811715635

  • #
  • #
  • #
#

Pharma & Healthcare

Global Feminine Protection Market (Sanitary Pads, Tampons & Pantyliner) (2018-2022 Edition)

Price: US$ 800.00 | Pages : 73 | Publish Date : May 2018

The global feminine protection market is expected to increase at high growth rates during the forecasted period (2018-2022). The global feminine protection market is supported by various growth drivers, such as increasing global female population, increasing disposable income, increase in urban popu...

Detail...

Global Acne Treatment Market: Size, Trends & Forecasts (2018-2022) Edition

Price: US$ 800.00 | Pages : 62 | Publish Date : May 2018

The global acne treatment market has shown upward trends over the past few years and projections are made that the market would grow at a steady pace over the forecasted period (2018-2022) also. Global acne treatment market is supported by a number of growth drivers such as rising disposable income,...

Detail...

Global Diaper (Adult and Baby Diaper) Market (2018-2022 Edition)

Price: US$ 800.00 | Pages : 68 | Publish Date : May 2018

The global diaper market is expected to increase at high growth rates during the forecasted period (2018-2022). The global diaper market is supported by various growth drivers, such as aging population, increasing disposable income, increase in urban population, delayed toilet training of children i...

Detail...

Global Healthcare CMO Market (2018-2022 Edition)

Price: US$ 800.00 | Pages : 63 | Publish Date : Apr 2018

The global healthcare CMO market has recorded a continuous growth since last few years and is expected to follow the same trend in coming years. The main driving factors for this growth are rise in global pharmaceutical industry, increased need for outsourcing, increased approvals and outsourcing of...

Detail...

Global Anticoagulants Market (2018-2022 Edition)

Price: US$ 800.00 | Pages : 66 | Publish Date : April 2018

The most commonly prescribed anticoagulant is Warfarin. Newer types of anticoagulants are also available and are becoming increasingly common. These include rivaroxaban (Xarelto), dabigatran (Pradaxa), apixaban (Eliquis), and edoxaban (Savaysa/Lixiana). Warfarin and the newer alternatives are taken ...

Detail...